Powder: -20°C for 3 years | In solvent: -80°C for 1 year
UB 165 fumarate is an agonist of the nAChR, a partial agonist of the α4β2 subtype, and a full agonist of the α3β2 subtype, with a Ki value of 0.27 nM for binding to [3H]-nicotine measured in rat brain.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 80,500 |
25 mg | 約6-8 週間 | ¥ 349,000 |
50 mg | 約6-8 週間 | ¥ 454,500 |
100 mg | 約6-8 週間 | ¥ 574,000 |
説明 | UB 165 fumarate is an agonist of the nAChR, a partial agonist of the α4β2 subtype, and a full agonist of the α3β2 subtype, with a Ki value of 0.27 nM for binding to [3H]-nicotine measured in rat brain. |
ターゲット&IC50 | Nicotine (rat brain):ki:0.27 nM , Nicotine (rat brain):0.27 nM(ki) |
In vitro | UB-165 fumarate exhibits an EC50 value of 88 nM for stimulating [3H]-dopamine release from striatal synaptosomes.[1] |
別名 | UB-165 fumarate, UB165 fumarate |
分子量 | 350.8 |
分子式 | C17H19ClN2O4 |
CAS No. | 2454492-43-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
UB 165 fumarate 2454492-43-2 Neuroscience AChR UB165 Fumarate UB-165 fumarate UB165 fumarate UB-165 Fumarate UB 165 Fumarate Inhibitor inhibitor inhibit